According to Zhitong Financial App, Sanai Health Group (01889) announced its interim results for the six months ended June 30, 2023, with revenue of 61.289 million yuan (RMB, same below), up 9.29% year on year; profit attributable to company owners was 15.543 million yuan, up 92.63% year on year; profit per share was 0.48 points.

According to reports, the increase in profit is mainly due to the fact that all sales of self-produced pharmaceutical products with high profit margins were transferred through the company's wholly-owned subsidiaries, rather than subsidiaries where the group owns 51% of the shares.